Coming Soon – September 2019 Peripheral arterial disease (PAD) is a...
Coming Soon – September 2019 Peripheral arterial disease (PAD) is a complex manifestation of underlying atherosclerotic disease and is a severely undertreated...
Coming Soon - September 2019 Physicians treating renal anemia are limited...
Coming Soon - September 2019 Physicians treating renal anemia are limited to iron supplements and erythropoietin-stimulating agents (ESAs), which, although effectiv...
Coming Soon – November 2019 Despite heart failure with preserved ejection...
Coming Soon – November 2019 Despite heart failure with preserved ejection fraction (HFpEF) accounting for approximately half of all chronic heart failure (CHF...
Coming Soon – March 2019 MARKET OUTLOOK TNF-α inhibitors (AbbVie’s...
Coming Soon – March 2019 MARKET OUTLOOK TNF-α inhibitors (AbbVie’s Humira, Amgen’s Enbrel,...
Coming Soon – April 2019 Insomnia is a highly prevalent sleep disorder...
Coming Soon – April 2019 Insomnia is a highly prevalent sleep disorder characterized by daytime dysfunction resulting from sleep problems. The treatment of insomnia is...
Coming Soon – May 2019 DED is one of the most common ocular conditions and...
Coming Soon – May 2019 DED is one of the most common ocular conditions and is characterized by insufficient tears to lubricate...
Coming soon – March 2019 Childhood absence epilepsy (CAE) is characterized...
Coming soon – March 2019 Childhood absence epilepsy (CAE) is characterized by frequent and brief absence seizures in children aged 4-12 years and is diagnosed in a...
Coming Soon – May 2019 The management of pediatric patients with moderate...
Coming Soon – May 2019 The management of pediatric patients with moderate to severe atopic dermatitis (AD) is poised for a transformation. Sanofi/Regeneron’...
Coming Soon – March 2019 MARKET OUTLOOK Roche/Genentech achieved a...
Coming Soon – March 2019 MARKET OUTLOOK Roche/Genentech achieved a clinical and regulatory milestone with the approval of Ocrevus fo...
As the term implies, levodopa-induced dyskinesia (LID) is a complication of...
As the term implies, levodopa-induced dyskinesia (LID) is a complication of chronic use of levodopa, the goldstandard of Parkinson’s disease...
The few currently available pharmacological treatments for opioid addiction...
The few currently available pharmacological treatments for opioid addiction fall into one of two categories: substitution therapies or abstinent therapies. Substitution therapies (i.e., methadone......
Coming soon – June 2019 Over the past two decades, in response to mounting...
Coming soon – June 2019 Over the past two decades, in response to mounting failures, clinical trials of disease-modifying therapies...
Coming Soon – June 2019 MARKET OUTLOOK No disease-modifying therapies...
Coming Soon – June 2019 MARKET OUTLOOK No disease-modifying therapies are approved to treat primary Sjögren’s...
Market Outlook Because no current therapy for type 2 diabetes offers disease...
Market Outlook Because no current therapy for type 2 diabetes offers disease-modifying capabilities, a high unmet need exists for drugs that can effectively control...
Market Outlook The treatment armamentarium of mCRPC has significantly...
Market Outlook The treatment armamentarium of mCRPC has significantly evolved with the addit...
MARKET OUTLOOK QUESTIONS ANSWERED What are the treatment drivers and...
MARKET OUTLOOK QUESTIONS ANSWERED What are the treatment drivers and goals for [[indication]]? What......
The genetic complexity and heterogeneity of gastric and GEJ adenocarcinoma...
The genetic complexity and heterogeneity of gastric and GEJ adenocarcinoma poses a significant challenge for the development of treatment strategies......
Market Outlook Despite the number of therapy options available, metastatic...
Market Outlook Despite the number of therapy options available, metastatic HR-positive/...
Market Outlook As one of the larger segments in the overall market for acute...
Market Outlook As one of the larger segments in the overall market for acute pain therapies, the treatment of postoperative pain has experienced substantial growth over......
MARKET OUTLOOK Pulmonary arterial hypertension (PAH) is a rare and life-...
MARKET OUTLOOK Pulmonary arterial hypertension (PAH) is a rare and life-threatening disorder marked by considerable......